View This Report »
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...
The global tumor ablation market is estimated to register a high CAGR of 12.5% during 2016-2021, and is expected to be valued at ~USD 580.1 million in 2021. Although mature markets (North America and Europe) ...
The nuclear imaging equipment market is projected to reach USD 2.85 billion by 2021 from USD 2.25 billion in 2016, growing at a CAGR of 4.8% in the next five years (2016 to 2021). Over the years, the nuclea ...